nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGR2—cardiovascular system—nicotine dependence	0.0298	0.0827	CbGeAlD
Indomethacin—PTGR2—midbrain—nicotine dependence	0.0232	0.0646	CbGeAlD
Indomethacin—PTGDR2—brain—nicotine dependence	0.022	0.0611	CbGeAlD
Indomethacin—Platelet count decreased—Varenicline—nicotine dependence	0.0208	0.0454	CcSEcCtD
Indomethacin—GLO1—cardiovascular system—nicotine dependence	0.0184	0.0511	CbGeAlD
Indomethacin—PLA2G2A—cardiovascular system—nicotine dependence	0.0171	0.0475	CbGeAlD
Indomethacin—ABCC6—cardiovascular system—nicotine dependence	0.0169	0.047	CbGeAlD
Indomethacin—PPARA—cardiovascular system—nicotine dependence	0.016	0.0444	CbGeAlD
Indomethacin—Glycosuria—Varenicline—nicotine dependence	0.0153	0.0333	CcSEcCtD
Indomethacin—PTGR2—brain—nicotine dependence	0.0146	0.0406	CbGeAlD
Indomethacin—GLO1—midbrain—nicotine dependence	0.0144	0.0399	CbGeAlD
Indomethacin—Tenderness—Varenicline—nicotine dependence	0.0142	0.0309	CcSEcCtD
Indomethacin—PLA2G2A—midbrain—nicotine dependence	0.0133	0.0371	CbGeAlD
Indomethacin—CXCL8—midbrain—nicotine dependence	0.0132	0.0367	CbGeAlD
Indomethacin—Dysarthria—Varenicline—nicotine dependence	0.0131	0.0285	CcSEcCtD
Indomethacin—Hyperkalaemia—Varenicline—nicotine dependence	0.0122	0.0265	CcSEcCtD
Indomethacin—CES1—cardiovascular system—nicotine dependence	0.0118	0.0329	CbGeAlD
Indomethacin—Mouth ulceration—Varenicline—nicotine dependence	0.0112	0.0244	CcSEcCtD
Indomethacin—AKR1C3—midbrain—nicotine dependence	0.0104	0.0288	CbGeAlD
Indomethacin—Deafness—Varenicline—nicotine dependence	0.01	0.0219	CcSEcCtD
Indomethacin—AKR1C3—Retinoid metabolism and transport—AKR1B10—nicotine dependence	0.01	0.0553	CbGpPWpGaD
Indomethacin—Eye pain—Varenicline—nicotine dependence	0.00996	0.0217	CcSEcCtD
Indomethacin—Hot flush—Varenicline—nicotine dependence	0.00961	0.0209	CcSEcCtD
Indomethacin—Menopausal symptoms—Varenicline—nicotine dependence	0.00953	0.0208	CcSEcCtD
Indomethacin—Hypoglycaemia—Varenicline—nicotine dependence	0.00921	0.0201	CcSEcCtD
Indomethacin—GLO1—brain—nicotine dependence	0.00902	0.0251	CbGeAlD
Indomethacin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00899	0.0196	CcSEcCtD
Indomethacin—Osteoarthritis—Varenicline—nicotine dependence	0.00899	0.0196	CcSEcCtD
Indomethacin—Psychotic disorder—Varenicline—nicotine dependence	0.00878	0.0191	CcSEcCtD
Indomethacin—PPARG—cardiovascular system—nicotine dependence	0.00878	0.0244	CbGeAlD
Indomethacin—PLA2G2A—brain—nicotine dependence	0.00839	0.0233	CbGeAlD
Indomethacin—CXCL8—brain—nicotine dependence	0.0083	0.0231	CbGeAlD
Indomethacin—Abdominal pain upper—Varenicline—nicotine dependence	0.00821	0.0179	CcSEcCtD
Indomethacin—Gastritis—Varenicline—nicotine dependence	0.00795	0.0173	CcSEcCtD
Indomethacin—PPARA—brain—nicotine dependence	0.00783	0.0218	CbGeAlD
Indomethacin—Abdominal distension—Varenicline—nicotine dependence	0.00782	0.017	CcSEcCtD
Indomethacin—Asthma—Varenicline—nicotine dependence	0.00777	0.0169	CcSEcCtD
Indomethacin—SLC10A1—brain—nicotine dependence	0.00753	0.0209	CbGeAlD
Indomethacin—Abdominal discomfort—Varenicline—nicotine dependence	0.00745	0.0162	CcSEcCtD
Indomethacin—PTGDR2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00724	0.0399	CbGpPWpGaD
Indomethacin—Pollakiuria—Varenicline—nicotine dependence	0.00718	0.0156	CcSEcCtD
Indomethacin—Weight increased—Varenicline—nicotine dependence	0.00707	0.0154	CcSEcCtD
Indomethacin—Hyperglycaemia—Varenicline—nicotine dependence	0.00701	0.0153	CcSEcCtD
Indomethacin—Depression—Varenicline—nicotine dependence	0.00691	0.015	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00687	0.015	CcSEcCtD
Indomethacin—Stomatitis—Varenicline—nicotine dependence	0.00675	0.0147	CcSEcCtD
Indomethacin—SLC22A7—brain—nicotine dependence	0.00671	0.0187	CbGeAlD
Indomethacin—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00669	0.0369	CbGpPWpGaD
Indomethacin—Epistaxis—Varenicline—nicotine dependence	0.00653	0.0142	CcSEcCtD
Indomethacin—AKR1C3—brain—nicotine dependence	0.00651	0.0181	CbGeAlD
Indomethacin—SLC22A6—brain—nicotine dependence	0.00648	0.018	CbGeAlD
Indomethacin—SLCO1A2—midbrain—nicotine dependence	0.00647	0.018	CbGeAlD
Indomethacin—Bradycardia—Varenicline—nicotine dependence	0.00633	0.0138	CcSEcCtD
Indomethacin—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0061	0.0337	CbGpPWpGaD
Indomethacin—Erythema multiforme—Varenicline—nicotine dependence	0.00588	0.0128	CcSEcCtD
Indomethacin—CES1—brain—nicotine dependence	0.00581	0.0162	CbGeAlD
Indomethacin—Tinnitus—Varenicline—nicotine dependence	0.0058	0.0126	CcSEcCtD
Indomethacin—Arrhythmia—Varenicline—nicotine dependence	0.00556	0.0121	CcSEcCtD
Indomethacin—Erythema—Varenicline—nicotine dependence	0.00541	0.0118	CcSEcCtD
Indomethacin—Flatulence—Varenicline—nicotine dependence	0.00533	0.0116	CcSEcCtD
Indomethacin—CYP2C9—cardiovascular system—nicotine dependence	0.00514	0.0143	CbGeAlD
Indomethacin—AKR1C3—Diseases associated with visual transduction—AKR1B10—nicotine dependence	0.00511	0.0282	CbGpPWpGaD
Indomethacin—Vision blurred—Varenicline—nicotine dependence	0.0051	0.0111	CcSEcCtD
Indomethacin—Ill-defined disorder—Varenicline—nicotine dependence	0.00502	0.0109	CcSEcCtD
Indomethacin—Anaemia—Varenicline—nicotine dependence	0.005	0.0109	CcSEcCtD
Indomethacin—Angioedema—Varenicline—nicotine dependence	0.00495	0.0108	CcSEcCtD
Indomethacin—Malaise—Varenicline—nicotine dependence	0.00488	0.0106	CcSEcCtD
Indomethacin—CES1—E2F transcription factor network—WASF1—nicotine dependence	0.00488	0.0269	CbGpPWpGaD
Indomethacin—Vertigo—Varenicline—nicotine dependence	0.00486	0.0106	CcSEcCtD
Indomethacin—Syncope—Varenicline—nicotine dependence	0.00485	0.0106	CcSEcCtD
Indomethacin—Palpitations—Varenicline—nicotine dependence	0.00478	0.0104	CcSEcCtD
Indomethacin—Loss of consciousness—Varenicline—nicotine dependence	0.00476	0.0104	CcSEcCtD
Indomethacin—ABCC3—brain—nicotine dependence	0.00474	0.0132	CbGeAlD
Indomethacin—PTGS1—cardiovascular system—nicotine dependence	0.00469	0.013	CbGeAlD
Indomethacin—Convulsion—Varenicline—nicotine dependence	0.00469	0.0102	CcSEcCtD
Indomethacin—Hypertension—Varenicline—nicotine dependence	0.00467	0.0102	CcSEcCtD
Indomethacin—Chest pain—Varenicline—nicotine dependence	0.00461	0.01	CcSEcCtD
Indomethacin—Anxiety—Varenicline—nicotine dependence	0.00459	0.01	CcSEcCtD
Indomethacin—Discomfort—Varenicline—nicotine dependence	0.00455	0.00992	CcSEcCtD
Indomethacin—PTGS2—cardiovascular system—nicotine dependence	0.00449	0.0125	CbGeAlD
Indomethacin—Oedema—Varenicline—nicotine dependence	0.00442	0.00963	CcSEcCtD
Indomethacin—PTGDR2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00438	0.0242	CbGpPWpGaD
Indomethacin—Shock—Varenicline—nicotine dependence	0.00435	0.00947	CcSEcCtD
Indomethacin—Thrombocytopenia—Varenicline—nicotine dependence	0.00433	0.00942	CcSEcCtD
Indomethacin—Tachycardia—Varenicline—nicotine dependence	0.00431	0.00939	CcSEcCtD
Indomethacin—PPARG—brain—nicotine dependence	0.00431	0.012	CbGeAlD
Indomethacin—Hyperhidrosis—Varenicline—nicotine dependence	0.00427	0.00931	CcSEcCtD
Indomethacin—Anorexia—Varenicline—nicotine dependence	0.00421	0.00918	CcSEcCtD
Indomethacin—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00415	0.0229	CbGpPWpGaD
Indomethacin—Hypotension—Varenicline—nicotine dependence	0.00413	0.00899	CcSEcCtD
Indomethacin—SLCO1A2—brain—nicotine dependence	0.00406	0.0113	CbGeAlD
Indomethacin—ALB—brain—nicotine dependence	0.00404	0.0112	CbGeAlD
Indomethacin—Insomnia—Varenicline—nicotine dependence	0.004	0.00871	CcSEcCtD
Indomethacin—Dyspnoea—Varenicline—nicotine dependence	0.00394	0.00858	CcSEcCtD
Indomethacin—Somnolence—Varenicline—nicotine dependence	0.00393	0.00856	CcSEcCtD
Indomethacin—ABCC4—brain—nicotine dependence	0.00391	0.0109	CbGeAlD
Indomethacin—Dyspepsia—Varenicline—nicotine dependence	0.00389	0.00847	CcSEcCtD
Indomethacin—SLC22A8—brain—nicotine dependence	0.00388	0.0108	CbGeAlD
Indomethacin—Decreased appetite—Varenicline—nicotine dependence	0.00384	0.00837	CcSEcCtD
Indomethacin—PPARA—Orphan transporters—GABRA4—nicotine dependence	0.00383	0.0212	CbGpPWpGaD
Indomethacin—Fatigue—Varenicline—nicotine dependence	0.00381	0.0083	CcSEcCtD
Indomethacin—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00378	0.0209	CbGpPWpGaD
Indomethacin—Constipation—Varenicline—nicotine dependence	0.00378	0.00823	CcSEcCtD
Indomethacin—Pain—Varenicline—nicotine dependence	0.00378	0.00823	CcSEcCtD
Indomethacin—Feeling abnormal—Varenicline—nicotine dependence	0.00364	0.00793	CcSEcCtD
Indomethacin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00361	0.00787	CcSEcCtD
Indomethacin—Urticaria—Varenicline—nicotine dependence	0.00351	0.00765	CcSEcCtD
Indomethacin—PTGS2—midbrain—nicotine dependence	0.0035	0.00974	CbGeAlD
Indomethacin—Abdominal pain—Varenicline—nicotine dependence	0.00349	0.00761	CcSEcCtD
Indomethacin—Body temperature increased—Varenicline—nicotine dependence	0.00349	0.00761	CcSEcCtD
Indomethacin—ABCC1—brain—nicotine dependence	0.00333	0.00927	CbGeAlD
Indomethacin—Hypersensitivity—Varenicline—nicotine dependence	0.00325	0.00709	CcSEcCtD
Indomethacin—Asthenia—Varenicline—nicotine dependence	0.00317	0.00691	CcSEcCtD
Indomethacin—AKR1C3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00314	0.0173	CbGpPWpGaD
Indomethacin—Pruritus—Varenicline—nicotine dependence	0.00313	0.00681	CcSEcCtD
Indomethacin—PTGDR2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00305	0.0168	CbGpPWpGaD
Indomethacin—Diarrhoea—Varenicline—nicotine dependence	0.00302	0.00659	CcSEcCtD
Indomethacin—Dizziness—Varenicline—nicotine dependence	0.00292	0.00637	CcSEcCtD
Indomethacin—AKR1C3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00292	0.0161	CbGpPWpGaD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00283	0.0156	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00282	0.0156	CbGpPWpGaD
Indomethacin—Vomiting—Varenicline—nicotine dependence	0.00281	0.00612	CcSEcCtD
Indomethacin—Rash—Varenicline—nicotine dependence	0.00279	0.00607	CcSEcCtD
Indomethacin—Dermatitis—Varenicline—nicotine dependence	0.00278	0.00606	CcSEcCtD
Indomethacin—ABCB1—cardiovascular system—nicotine dependence	0.00277	0.00771	CbGeAlD
Indomethacin—Headache—Varenicline—nicotine dependence	0.00277	0.00603	CcSEcCtD
Indomethacin—ABCC11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00276	0.0153	CbGpPWpGaD
Indomethacin—Nausea—Varenicline—nicotine dependence	0.00262	0.00572	CcSEcCtD
Indomethacin—PTGDR2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00248	0.0137	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00243	0.0134	CbGpPWpGaD
Indomethacin—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00242	0.0134	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00242	0.0133	CbGpPWpGaD
Indomethacin—PTGS1—brain—nicotine dependence	0.0023	0.0064	CbGeAlD
Indomethacin—PTGDR2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00225	0.0124	CbGpPWpGaD
Indomethacin—PTGDR2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00221	0.0122	CbGpPWpGaD
Indomethacin—PTGS2—brain—nicotine dependence	0.0022	0.00612	CbGeAlD
Indomethacin—ABCB1—midbrain—nicotine dependence	0.00217	0.00602	CbGeAlD
Indomethacin—ABCC6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0021	0.0116	CbGpPWpGaD
Indomethacin—UGT2B7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00206	0.0114	CbGpPWpGaD
Indomethacin—PTGDR2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00205	0.0113	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—FGD1—nicotine dependence	0.00194	0.0107	CbGpPWpGaD
Indomethacin—UGT2B7—Biological oxidations—CYP2A7—nicotine dependence	0.00194	0.0107	CbGpPWpGaD
Indomethacin—UGT2B7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00192	0.0106	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—OPRM1—nicotine dependence	0.00185	0.0102	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—FGD1—nicotine dependence	0.00176	0.00973	CbGpPWpGaD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00175	0.00968	CbGpPWpGaD
Indomethacin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00172	0.00951	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—TAS2R16—nicotine dependence	0.00171	0.00942	CbGpPWpGaD
Indomethacin—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0017	0.00938	CbGpPWpGaD
Indomethacin—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00167	0.00924	CbGpPWpGaD
Indomethacin—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00167	0.00924	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00161	0.0089	CbGpPWpGaD
Indomethacin—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00158	0.00871	CbGpPWpGaD
Indomethacin—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00158	0.00871	CbGpPWpGaD
Indomethacin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00157	0.00867	CbGpPWpGaD
Indomethacin—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00156	0.00859	CbGpPWpGaD
Indomethacin—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00156	0.00859	CbGpPWpGaD
Indomethacin—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00155	0.00855	CbGpPWpGaD
Indomethacin—CXCL8—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00146	0.00808	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00145	0.00799	CbGpPWpGaD
Indomethacin—CXCL8—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00141	0.00777	CbGpPWpGaD
Indomethacin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0014	0.00771	CbGpPWpGaD
Indomethacin—ABCB1—brain—nicotine dependence	0.00136	0.00378	CbGeAlD
Indomethacin—PTGDR2—GPCR ligand binding—DRD2—nicotine dependence	0.00134	0.00737	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TAS2R16—nicotine dependence	0.00133	0.00733	CbGpPWpGaD
Indomethacin—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00129	0.0071	CbGpPWpGaD
Indomethacin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00127	0.00703	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00119	0.00656	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—DRD2—nicotine dependence	0.00107	0.0059	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00104	0.00576	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—FGD1—nicotine dependence	0.00104	0.00575	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00104	0.00572	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000965	0.00532	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—OPRM1—nicotine dependence	0.000948	0.00523	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000945	0.00521	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000936	0.00516	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKR1B10—nicotine dependence	0.000921	0.00508	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000912	0.00503	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TAS2R16—nicotine dependence	0.000876	0.00483	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—CCAR1—nicotine dependence	0.000875	0.00483	CbGpPWpGaD
Indomethacin—CXCL8—G alpha (i) signalling events—DRD2—nicotine dependence	0.000859	0.00474	CbGpPWpGaD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000828	0.00457	CbGpPWpGaD
Indomethacin—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000787	0.00434	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—DRD2—nicotine dependence	0.000767	0.00423	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—FGD1—nicotine dependence	0.000757	0.00418	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR downstream signaling—DRD2—nicotine dependence	0.000755	0.00416	CbGpPWpGaD
Indomethacin—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000742	0.00409	CbGpPWpGaD
Indomethacin—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000732	0.00404	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—OPRM1—nicotine dependence	0.00072	0.00397	CbGpPWpGaD
Indomethacin—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000718	0.00396	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000709	0.00391	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000696	0.00384	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—CYP2A7—nicotine dependence	0.000691	0.00381	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—FGD1—nicotine dependence	0.000687	0.00379	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—DRD2—nicotine dependence	0.000685	0.00378	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000683	0.00377	CbGpPWpGaD
Indomethacin—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000677	0.00373	CbGpPWpGaD
Indomethacin—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000667	0.00368	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000667	0.00368	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TAS2R16—nicotine dependence	0.000656	0.00362	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKR1B10—nicotine dependence	0.000649	0.00358	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—WASF2—nicotine dependence	0.000649	0.00358	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—CCAR1—nicotine dependence	0.000627	0.00346	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—WASF1—nicotine dependence	0.000622	0.00343	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000618	0.00341	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—CYP2A7—nicotine dependence	0.000588	0.00324	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000581	0.0032	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000562	0.0031	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—OPRM1—nicotine dependence	0.00056	0.00309	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000556	0.00307	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000528	0.00291	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—DRD2—nicotine dependence	0.00052	0.00287	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TAS2R16—nicotine dependence	0.000518	0.00286	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—FGD1—nicotine dependence	0.000515	0.00284	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—CYP2A7—nicotine dependence	0.000506	0.00279	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKR1B10—nicotine dependence	0.000455	0.00251	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—CYP2A7—nicotine dependence	0.000438	0.00242	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—OPRM1—nicotine dependence	0.000407	0.00224	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FGD1—nicotine dependence	0.000406	0.00224	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—DRD2—nicotine dependence	0.000405	0.00223	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—OPRM1—nicotine dependence	0.000369	0.00204	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKR1B10—nicotine dependence	0.000359	0.00198	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKR1B10—nicotine dependence	0.000334	0.00184	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CYP2A7—nicotine dependence	0.000332	0.00183	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CYP2A7—nicotine dependence	0.000332	0.00183	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—WASF2—nicotine dependence	0.00032	0.00177	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CYP2A7—nicotine dependence	0.000314	0.00173	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—WASF1—nicotine dependence	0.000307	0.00169	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000302	0.00166	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—DRD2—nicotine dependence	0.000294	0.00162	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000289	0.0016	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—OPRM1—nicotine dependence	0.000277	0.00153	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.00027	0.00149	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.00027	0.00149	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—DRD2—nicotine dependence	0.000267	0.00147	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000264	0.00146	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.00026	0.00144	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—WASF2—nicotine dependence	0.000253	0.00139	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000247	0.00136	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—WASF1—nicotine dependence	0.000242	0.00134	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKR1B10—nicotine dependence	0.000224	0.00124	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.00022	0.00121	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—OPRM1—nicotine dependence	0.000218	0.0012	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—DRD2—nicotine dependence	0.0002	0.0011	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP2A7—nicotine dependence	0.000175	0.000964	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—DRD2—nicotine dependence	0.000158	0.00087	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP2A7—nicotine dependence	0.000141	0.00078	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000127	0.0007	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000124	0.000683	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000116	0.000638	CbGpPWpGaD
